How the Main Street Pharmacy Access Act Advances Pharmacist Provider Status

If signed, The Main Street Pharmacy Access Act embeds pharmacists into the Social Security Act as billable Medicare Part B providers and gives them the federal authority to test, treat, and vaccinate for some of the most common infectious diseases affecting Americans today. However, the bill, which has seen name changes and multiple renditions over the years, still has to make its journey to Capitol Hill as pharmacy professionals advocate for its passing.

In this week’s episode of the Over the Counter podcast, Drug Topics® catches back up with Chad Worz, PharmD, BCGP, FASCP, executive director and CEO of the American Society of Consultant Pharmacists (ASCP). Previously joining to discuss PBM reform from earlier in the year, as well as key provisions behind the Inflation Reduction Act, Worz has returned to provide a detailed breakdown of the transformation this bill will create for practicing pharmacists across the country.

READ MORE: Pharmacy Leaders Set Priorities for Global Primary Care Integration

Worz explains that while the legislative title has evolved over time, the fundamental goal of the bill remains unchanged.

What the Legislation Does for Pharmacists

Initially introduced under the Biden Administration as the Equitable Community Access to Pharmacist Services (ECAPS) Act, to align with federal health equity priorities, the measure was rebranded as the Ensuring Community Access to Pharmacists Act during the Trump Administration. Still with the same ECAPS moniker, just prior to advancing out of the House Committee on Ways and Means, lawmakers renamed the policy to the “Main Street Pharmacy Access Act.”¹

At its core, the bill establishes a long-sought test, treat, and vaccinate framework in federal law.

The legislation codifies federal flexibilities that allowed pharmacy professionals to safeguard public health during the COVID-19 pandemic. Under the statute, pharmacists gain explicit authority to manage common respiratory conditions, including influenza, pneumococcal disease, COVID-19, and RSV.

In practice, a patient visiting a community pharmacy can be tested for an upper respiratory infection and, if positive, immediately receive appropriate treatments ordered by the pharmacist. The law also solidifies pharmacist authority to administer preventive vaccines for these conditions.

Securing Long Overdue Medicare Recognition

For decades, the pharmacy profession has pursued formal inclusion in the Social Security Act as recognized health care providers capable of billing Medicare.

Although the term “provider status” has sometimes felt alienating in health policy discussions, inserting pharmacists into federal statute creates a permanent foundation for clinical billing. This statutory shift simplifies future administrative efforts to expand billing for chronic disease management, such as diabetes care.

The momentum behind H.R. 3164 reached a key milestone when the House Committee on Ways and Means passed the legislation. The National Association of Chain Drug Stores (NACDS) praised bipartisan leaders for driving the bill forward. Industry leaders emphasized that expanding pharmacist care delivers timely assistance close to home while lowering overall health care costs.¹

Operating approximately 32,000 retail pharmacies nationwide, chain drug stores, supermarkets, and independent pharmacies represent accessible health care destinations across American communities.

Implementation Opportunities and Workforce Readiness

Despite broad support, pharmacy leaders acknowledge that legislative passage is only a first step.

Drawing parallels to PBM reform, Worz cautions that statutory authority must be paired with workforce readiness across practice settings. During the pandemic, long-term care pharmacies successfully expanded clinical operations to deliver vaccinations, demonstrating professional adaptability.

However, sustaining these clinical roles requires continuous engagement so practitioners fully utilize new billing authorities. Consequently, pharmacy schools and national associations are developing targeted training programs to ensure pharmacists are prepared for expanded practice.

Transforming Community Health Care Delivery

As the Main Street Pharmacy Access Act advances, the prospective law offers a clear path toward practicing at the top of the pharmacist’s license.

By bridging preventive care and immediate treatment, neighborhood pharmacies can serve as vital care access points for Medicare beneficiaries. For practicing pharmacists across the country, enactment of H.R. 3164 represents both the culmination of decades of advocacy and a new chapter in clinical practice.¹

READ MORE: Law and Regulations Resource Center

REFERENCE

NACDS applauds House Ways and Means Committee passage of legislation expanding seniors’ access to pharmacy services. NACDS. News Release. May 21, 2026. Accessed September 18, 2026. https://www.nacds.org/nacds-applauds-house-ways-and-means-committee-passage-of-legislation-expanding-seniors-access-to-pharmacy-services/